...
首页> 外文期刊>Journal of Anaesthesiology Clinical Pharmacology >Efficacy of tramadol and butorphanol pretreatment in reducing pain on propofol injection: A placebo-controlled randomized study
【24h】

Efficacy of tramadol and butorphanol pretreatment in reducing pain on propofol injection: A placebo-controlled randomized study

机译:曲马多和布托啡诺预处理对减轻异丙酚注射液疼痛的功效:一项安慰剂对照的随机研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background and Aims: Pain of propofol injection has been recalled by many patients as the most painful part of the induction of anesthesia. Tramadol and butorphanol are commonly used analgesics for perioperative analgesia in anesthesia practice. However, their potential to relieve propofol injection pain still needs to be explored. Material and Methods: A randomized, double-blind, placebo-controlled study was conducted on 90 American Society of Anesthesiologists I and II adult patients undergoing elective surgery under general anesthesia with propofol as an induction agent. Consecutive sampling technique with random assignment was used to allocate three groups of 30 patients each. Group I patients received an injection of normal saline 3 ml intravenously (placebo) while Group II and Group III patients received injection of tramadol 50 mg and butorphanol 1 mg intravenously, respectively. Before induction of anesthesia patients were asked about the intensity of pain on propofol injection by using visual analog scale (VAS) before the loss of consciousness. Descriptive statistics and analysis of variance with Chi-square test were used to analyze the data. The value of P P Results: The incidence of pain in Group I was observed in 80% of the patients, while it was observed in 23.33% and 20% of patients in Group II and III, respectively. Mean VAS scores were 2.27 ± 1.51, 1.14 ± 1.74, and 1.03 ± 1.72 in Group I, II, and Group III patients, respectively. The incidence of pruritus was 10% and 6.7% and erythema in 13.2% and 6.7% in Group II and III, respectively. Conclusion: Pretreatment with both butorphanol and tramadol significantly reduced pain on propofol injection; however, they exhibited comparable efficacy among each other. Thus, either of these two drugs can be considered for pretreatment to reduce propofol injection pain.
机译:背景与目的:异丙酚注射痛已被许多患者召回,是麻醉诱导中最痛苦的部分。在麻醉实践中曲马多和布托啡诺是围手术期镇痛常用的镇痛药。然而,它们缓解丙泊酚注射痛的潜力仍然有待探索。材料与方法:一项随机,双盲,安慰剂对照研究是针对90名美国麻醉医师协会I和II成年患者在异丙酚作为诱导剂的情况下在全身麻醉下进行择期手术的。采用随机分配的连续抽样技术将三组患者各分配30位患者。 I组患者静脉注射3 ml生理盐水(安慰剂),而II组和III组患者分别静脉注射曲马多50 mg和布托啡诺1 mg。在麻醉之前,患者会在失去知觉之前通过视觉模拟量表(VAS)询问异丙酚注射时的疼痛程度。描述性统计和卡方检验方差分析用于分析数据。 P P结果的价值:第一组的疼痛发生率在80%的患者中观察到,而第二组和第三组的疼痛发生率分别在23.33%和20%的患者中观察到。 I,II和III组患者的平均VAS评分分别为2.27±1.51、1.14±1.74和1.03±1.72。第二组和第三组的瘙痒发生率分别为10%和6.7%,红斑的发生率分别为13.2%和6.7%。结论:布托啡诺和曲马多联合预处理可显着减轻异丙酚注射液的疼痛。但是,它们彼此之间表现出可比的功效。因此,可以考虑将这两种药物中的任一种用于减轻丙泊酚注射疼痛的预处理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号